全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

查看量下载量

相关文章

更多...

microRNA-29a对肥大心肌细胞细胞周期的影响研究
Study of miR-29a in Myocardial Hypertrophy Cell Cycle

DOI: 10.12677/HJBM.2019.93019, PP. 128-134

Keywords: 心肌肥大，细胞周期，miR-29a
Cardiac Hypertrophy, Cell Cycle, miR-29a

Full-Text   Cite this paper   Add to My Lib

Abstract:

心血管疾病严重威胁人类健康，其中心肌肥大和心肌纤维化是心血管疾病发展的主要表现。microRNA-29在心肌肥大和纤维化过程中都发生异常表达，并且参与纤维化、肿瘤增殖等过程。本研究通过建立肥大心肌细胞体外模型，研究miR-29a在心肌肥大过程中的变化水平及肥大心肌细胞细胞周期相关蛋白的表达模式变化。将常规培养H9C2心肌细胞系使用1 × 10？5、1 × 10？6和1 × 1？7 mol/L浓度的AngII诱导48 h后，检测细胞面积、细胞总蛋白含量，确定肥大心肌细胞诱导结果；再利用qPCR方法检测不同组的miR-29a、Cyclin A2、Bcl-2、Plk-1表达水平。结果显示使用浓度为1 × 10？5、1 × 10？6 mol/L的AngII对H9C2诱导48 h后，细胞面积明显增大，细胞的总蛋白含量也增加，并且miR-29a表达水平显著升高；细胞周期相关的CyclinA2、Bcl-2和Plk-1在高浓度(1 × 10？5 mol/L) AngII诱导后表达水平上升，低浓度(1 × 10？7 mol/L) AngII诱导后表达水平下降。在肥大心肌模型建立过程中，miR-29a可能能够对细胞周期相关基因产生抑制。
Cardiovascular disease is a serious threat to human health, among which myocardial hypertrophy and myocardial fibrosis are the main manifestations of the development of cardiovascular disease. microRNA-29 was abnormally expressed in the process of myocardial hypertrophy and fibrosis, and was involved in fibrosis, tumor proliferation and other processes. In this study, an in vitro model of hypertrophic cardiomyocytes was established to study the changes of miR-29a in the process of cardiac hypertrophy and the changes of cell cycle related protein expression patterns in hypertrophic cardiomyocytes. H9C2 cardiomyocytes were induced with AngII at concentrations of 1 × 10？5、1 × 10？6 and 1 × 1？7 mol/L for 48 h, the cell area and total protein content were detected. The expression levels of miR-29a, Cyclin A2, Bcl-2 and Plk-1 in different

References

[1]  Shimizu, I. and Minamino, T. (2016) Physiological and Pathological Cardiac Hypertrophy. Journal of Molecular and Cellular Cardiology, 97, 245-262.
https://doi.org/10.1016/j.yjmcc.2016.06.001
[2]  Tuomainen, T. and Tavi, P. (2017) The Role of Cardiac Energy Metabolism in Cardiac Hypertrophy and Failure. Experimental Cell Research, 360, 12-18.
https://doi.org/10.1016/j.yexcr.2017.03.052
[3]  Berkin, K.E. and Ball, S.G. (2001) Essential Hypertension: The Heart and Hypertension. Heart, 86, 467-475.
https://doi.org/10.1136/heart.86.4.467
[4]  Cordes, K.R. and Srivastava, D. (2009) MicroRNA Regulation of Cardiovascular Development. Circulation Research, 104, 724-732.
https://doi.org/10.1161/CIRCRESAHA.108.192872
[5]  Thum, T., et al. (2007) MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure. Circulation, 116, 258-267.
https://doi.org/10.1161/CIRCULATIONAHA.107.687947
[6]  Van Rooij, E., et al. (2006) A Signature Pattern of Stress-Responsive microRNAs That Can Evoke Cardiac Hypertrophy and Heart Failure. Proceedings of the National Academy of Sciences of the United States of America, 103, 18255-18260.
https://doi.org/10.1073/pnas.0608791103
[7]  Zuo, X., et al. (2012) Nicorandil Prevents Right Ventricular Re-modeling by Inhibiting Apoptosis and Lowering Pressure Overload in Rats with Pulmonary Arterial Hypertension. PLoS ONE, 7, e44485.
https://doi.org/10.1371/journal.pone.0044485
[8]  Oliveiracarvalho, V., et al. (2013) MicroRNAs: New Players in Heart Failure. Molecular Biology Reports, 40, 2663- 2670.
https://doi.org/10.1007/s11033-012-2352-y
[9]  Van Rooij, E., et al. (2008) Dysregulation of microRNAs after Myocardial Infarction Reveals a Role of miR-29 in Cardiac Fibrosis. Proceedings of the National Academy of Sciences of the United States of America, 105, 13027-13032.
https://doi.org/10.1073/pnas.0805038105
[10]  Roncarati, R., et al. (2014) Circulating miR-29a, among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients with Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology, 63, 920-927.
https://doi.org/10.1016/j.jacc.2013.09.041
[11]  Wu, Z., et al. (2013) The Inhibitory Role of Mir-29 in Growth of Breast Cancer Cells. Journal of Experimental & Clinical Cancer Research, 32, 98.
https://doi.org/10.1186/1756-9966-32-98
[12]  Wang, Y., et al. (2013) The Role of miRNA-29 Family in Cancer. European Journal of Cell Biology, 92, 123-128.
https://doi.org/10.1016/j.ejcb.2012.11.004
[13]  Cui, Y., et al. (2011) MiR-29a Inhibits Cell Proliferation and In-duces Cell Cycle Arrest through the Downregulation of p42.3 in Human Gastric Cancer. PLoS ONE, 6, e25872.
https://doi.org/10.1371/journal.pone.0025872
[14]  宋洋柳. GATA4招募PCG蛋白介导miR-29a表达调控C2C12细胞增殖与分化的机制研究[D]: [硕士学位论文]. 郑州: 郑州大学, 2016.
[15]  招霞. PTEN-PI3K-PDK1-Akt信号通路对心脏发育和心脏功能作用的研究[D]: [博士学位论文]. 南京: 南京大学, 2012.
[16]  王晓. microRNA-29a在肝癌患者中的表达及对肝癌细胞增殖、迁移能力的研究[D]: [博士学位论文]. 郑州: 郑州大学, 2017.
[17]  王慧玲, 等. miR-29a调控HDAC4促肝癌细胞增殖和转移的机制研究[J]. 胃肠病学和肝病学杂志, 2017, 26(4): 381-385.
[18]  王慧玲, 等. miR-29a调控IRS1促进肝门部胆管癌细胞增殖的机制研究[J]. 胃肠病学和肝病学杂志, 2019, 28(4): 456-460.
[19]  Ramdas, V., et al. (2013) Canonical Transforming Growth Factor-Beta Signaling Regulates Disintegrin Metalloprotease Expression in Experimental Renal Fibrosis via miR-29. The American Journal of Pathology, 183, 1885-1896.
https://doi.org/10.1016/j.ajpath.2013.08.027
[20]  李晓, 等. miR-29a调控心肌肥大的分子机制研究[J]. 现代中西医结合杂志, 2017, 26(13): 1379-1381+1385.
[21]  Yuan, J., et al. (2011) Polo-Box Domain Inhibitor Poloxin Ac-tivates the Spindle Assembly Checkpoint and Inhibits Tumor Growth in Vivo. The American Journal of Pathology, 179, 2091-2099.
https://doi.org/10.1016/j.ajpath.2011.06.031
[22]  Kobayashi, Y., et al. (2015) Phase I Trial of Volasertib, a Po-lo-Like Kinase Inhibitor, in Japanese Patients with Acute Myeloid Leukemia. Cancer Science, 106, 1590-1595.
https://doi.org/10.1111/cas.12814
[23]  Harris, P.S., et al. (2012) Polo-Like Kinase 1 (PLK1) Inhibition Suppresses Cell Growth and Enhances Radiation Sensitivity in Medulloblastoma Cells. BMC Cancer, 12, 80.
https://doi.org/10.1186/1471-2407-12-80
[24]  Zhang, N., et al. (2016) Cardiac Ankyrin Repeat Protein Attenuates Cardiomyocyte Apoptosis by Upregulation of Bcl-2 Expression. Biochimica et Biophysica Acta, 1863, 3040-3049.
https://doi.org/10.1016/j.bbamcr.2016.09.024
[25]  Xiong, Y., et al. (2010) Effects of microRNA-29 on Apoptosis, Tumorigenicity, and Prognosis of Hepatocellular Carcinoma. Hepatology, 51, 836-845.
https://doi.org/10.1002/hep.23380
[26]  Jafarinejad-Farsangi, S., et al. (2015) MicroRNA-29a Induces Apoptosis via Increasing the Bax:Bcl-2 Ratio in Dermal Fibroblasts of Patients with Systemic Sclerosis. Autoimmunity, 48, 369-378.
https://doi.org/10.3109/08916934.2015.1030616
[27]  Chaudhry, H.W., et al. (2004) Cyclin A2 Mediates Cardiomyocyte Mitosis in the Postmitotic Myocardium. The Journal of Biological Chemistry, 279, 35858-35866.
https://doi.org/10.1074/jbc.M404975200
[28]  Anversa, P. and Kajstura, J. (1998) Ventricular Myocytes Are Not Terminally Differentiated in the Adult Mammalian Heart. Circulation Research, 83, 1-14.
https://doi.org/10.1161/01.RES.83.1.1
[29]  Beltrami, A.P., et al. (2001) Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction. The New England Journal of Medicine, 344, 1750-1757.
https://doi.org/10.1056/NEJM200106073442303
[30]  Brooks, G., et al. (1997) Expression and Activities of Cy-clins and Cyclin-Dependent Kinases in Developing Rat Ventricular Myocytes. Journal of Molecular and Cellular Car-diology, 29, 2261-2271.
https://doi.org/10.1006/jmcc.1997.0471

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133